Karyopharm Therapeutics Stock Statistic Functions Beta
| KPTI Stock | USD 6.92 0.13 1.84% |
| Symbol |
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Karyopharm Therapeutics correlated with the market. If Beta is less than 0 Karyopharm Therapeutics generally moves in the opposite direction as compared to the market. If Karyopharm Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Karyopharm Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Karyopharm Therapeutics is generally in the same direction as the market. If Beta > 1 Karyopharm Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
Karyopharm Therapeutics Technical Analysis Modules
Most technical analysis of Karyopharm Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Karyopharm from various momentum indicators to cycle indicators. When you analyze Karyopharm charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Karyopharm Therapeutics Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Karyopharm Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Karyopharm Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Karyopharm Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Karyopharm Therapeutics's daily price indicators and compare them against related drivers, such as statistic functions and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Karyopharm Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Karyopharm Therapeutics, we also check how macroeconomic factors affect Karyopharm Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 1.58 | 1.18 | 1.35 | 1.29 | Days Of Inventory On Hand | 224.75 | 287.95 | 259.16 | 221.1 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Karyopharm Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Become your own money manager
As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.Did you try this?
Run Commodity Channel Now
Commodity ChannelUse Commodity Channel Index to analyze current equity momentum |
| All Next | Launch Module |
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested over 40 shares | |
 | Dividend Beast Invested over 30 shares | |
 | Hedge Favorites Invested over 30 shares | |
 | Warren Buffett Holdings Invested over 50 shares | |
 | Impulse Invested over 200 shares | |
 | Adviser Favorites Invested few shares | |
 | Artificial Intelligence Invested few shares | |
 | Climate Change Invested over 90 shares | |
 | Technology Invested few shares | |
 | SRI Sustainable Growth Invested few shares | |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Karyopharm Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For more detail on how to invest in Karyopharm Stock please use our How to Invest in Karyopharm Therapeutics guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is there potential for Biotechnology market expansion? Will Karyopharm introduce new products? Factors like these will boost the valuation of Karyopharm Therapeutics. Expected growth trajectory for Karyopharm significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Karyopharm Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (14.70) | Revenue Per Share | Quarterly Revenue Growth 0.136 | Return On Assets | Return On Equity |
The market value of Karyopharm Therapeutics is measured differently than its book value, which is the value of Karyopharm that is recorded on the company's balance sheet. Investors also form their own opinion of Karyopharm Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Karyopharm Therapeutics' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Karyopharm Therapeutics' market value can be influenced by many factors that don't directly affect Karyopharm Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Karyopharm Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Karyopharm Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Karyopharm Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.